| Application no. and date | 20800444.0 (espacenet) (Federated) (European Patent Register), 20201009 | | Patent/reg. no. and date | DK/EP 4041713, 20241211 | | Publication date | 20220817 | | Priority no. and date | US 201962913574 P, 20191010 | | EP pub. no. and date |
EP 4041713 20220817 | | Effective date | | | Applicant/owner | Xenon Pharmaceuticals Inc., 3650 Gilmore Way
Burnaby, BC V5G 4W8, CA | | Applicant ref. no. | 2003026 | | Inventor | BEATCH, Gregory N., 6994 Hycroft Road West
Vancouver, British Columbia V7W 2H8, CA,
BICHLER, Paul Robert, 691 Third Avenue
Fernie, British Columbia V0B 1M0, CA,
CADIEUX, Jean-Jacques A., 58-9229 University Crescent
Burnaby, British Columbia V5A 4Z2, CA,
TANDY, Matthew David, 3015 East Broadway
Vancouver, British Columbia V5M 1Z3, CA | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/472 (2006.01) , A61P 25/08 (2006.01) , C07D 217/04 (2006.01) | | Title | FASTFASEKRYSTALFORMER AF EN SELEKTIV KALIUMKANALMODULATOR | | Int. application no. | US2020055129 | | Int. publication no. | WO2021072307 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
